Interstitial lung disease (ILD) is a group of diseases with
|
|
- Sheila Hubbard
- 5 years ago
- Views:
Transcription
1 Diagnostic Surgical Lung Biopsies for Suspected Interstitial Lung Diseases: A Retrospective Study Martin I. Sigurdsson, MD, Helgi J. Isaksson, MD, Gunnar Gudmundsson, MD, PhD, and Tomas Gudbjartsson, MD, PhD Departments of Cardiothoracic Surgery, Pathology, and Respiratory Medicine, Landspitali University Hospital, and Faculty of Medicine, University of Iceland, Reykjavik, Iceland Background. Current guidelines for interstitial lung disease support a surgical biopsy for optimal diagnosis and treatment, yet only a minority of patients undergo such biopsy. Our objectives were to address the properties of a surgical lung biopsy for suspected interstitial lung disease, the diagnostic yield of the procedure, and whether it resulted in changes in diagnosis and treatment. Methods. A retrospective nationwide study including 73 patients (mean age, 57.3 years; 58% males) who underwent a surgical lung biopsy for suspected interstitial disease in Iceland between 1986 and 2007 was conducted. Patient records and histologic specimens were reviewed. Before the surgical biopsy a transbronchial or computed tomography guided biopsy had been performed in two thirds of the patients. Results. The complication rate for surgical lung biopsy was 16%, and 30-day operative mortality was 2.7%, both significantly higher in patients with preoperative respiratory failure. After the procedure, a definite histopathologic diagnosis was obtained in 81% of the patients. Usual interstitial pneumonia was the most common diagnosis (31%). The clinical diagnosis was changed for 73% of the patients, and in 53% of the patients the biopsy resulted in changes in treatment. Conclusions. Surgical lung biopsy is a powerful tool for diagnosis of suspected interstitial lung disease. It results in a specific diagnosis for the majority of patients and changes in treatment for more than half. Operative morbidity and mortality are low but still significant, so patients should be carefully selected for the procedure, especially those with respiratory failure. (Ann Thorac Surg 2009;88:227 32) 2009 by The Society of Thoracic Surgeons Interstitial lung disease (ILD) is a group of diseases with great diversity regarding treatment options and prognosis. The current classification of ILD and guidelines support a surgical lung biopsy (SLB) for definite diagnosis of ILD but encourage physicians to balance the benefit carefully against the risks of performing the surgery [1, 2]. Increased quality of both high-resolution computerized tomography and transbronchial biopsies obtained through bronchoscopy has raised the question of necessity for SLBs [3]. Together with clinical information, specificity and sensitivity of these diagnostic measures are in the 60% to 80% range [4, 5]. Recently accurate diagnosis of idiopathic pulmonary fibrosis using only radiologic and clinical data has been demonstrated [6]; however, this approach is highly dependent on physician expertise [7]. Also, transbronchial biopsies are less accurate for diseases when a substantial amount of tissue is required for histologic diagnosis (such as idiopathic pulmonary fibrosis) [8]. According to recent studies postoperative mortality after SLB is 4.3% to 4.8% [9, 10]. However, some subgroups of patients, ie, immunocompromised patients or patients with severe respiratory failure, have substantially higher operative mortality [9, 10]. The shift from conventional thoracotomy toward video-assisted thoracoscopic surgery (VATS) Accepted for publication April 1, Address correspondence to Prof Gudbjartsson, Landspitali University Hospital, Hringbraut, Reykjavik, 101, Iceland; tomasgud@landspitali.is. favors the new technique in regards to mortality [11] and hospital stay [12]. However, many physicians are still reluctant to refer their patients for SLB for suspected ILD. For instance a recent study from Iceland revealed that the percentage of patients diagnosed with organizing pneumonia using SLB was only 22% [13]. The contribution of SLB to the final diagnosis and treatment selection has not been previously documented. In the study of Lettieri and colleagues [10] on patients with suspected idiopathic pulmonary fibrosis, the final diagnosis was changed for 40% of the patients after an SLB. This study, however, neither addressed the initiated treatment changes nor did it include patients suspected of having other ILDs. We therefore designed a study to address these issues in a population-based cohort of patients with suspected ILD. For the study we used our nationwide database that includes all SLBs performed in Iceland for 22 years from The main objectives of this study were to address the diagnostic yield of SLB for suspected ILD, the risks of the procedure, and whether the results of the biopsy led to changes in treatment. Patients and Methods Patient Identification All patients undergoing SLB for suspected ILD during a 22-year period between January 1, 1986, and December 2009 by The Society of Thoracic Surgeons /09/$36.00 Published by Elsevier Inc doi: /j.athoracsur
2 228 SIGURDSSON ET AL Ann Thorac Surg SURGICAL LUNG BIOPSIES 2009;88: , 2007, were identified through two registries separately. During the study period, the average number of people living in Iceland was 273,052 (minimum of 242,203 in 1986, maximum of 315,459 in 2007; Icelandic National Registry). A computerized diagnosis and operation registry was used to identify patients undergoing open or thoracoscopic lung biopsy at Landspitali University Hospital (the single institution performing pulmonary surgery in Iceland). Furthermore a centralized pathology registry from the Department of Pathology implementing the Systematized Nomenclature of Medicine codes was used to identify patients who had a part of lung biopsied. All patients undergoing a surgical lung biopsy through thoracoscopy or an open surgery were evaluated for the study. Patients with a solitary pulmonary nodule or patients in whom the surgery was used to remove foreign bodies or for treatment of recurrent pulmonary infections were excluded. As a quality control, the list of patients was compared with an ILD patient registry, confirming a 100% match with the subset diagnosed with SLB. Patients were assigned a date and a cause of death or identified as living on December 31, 2007, using data from the Icelandic National Registry. Mean follow-up time was 72.5 months (range, 0 to 259 months), and no patients were lost to follow-up. The study was approved by the Icelandic National Bioethics Committee and the Icelandic Data Protection Commission. As individual patients were not identified, individual consent for the study was waived. Clinical Data Clinical data were collected retrospectively from clinical records from hospitals and private offices using a standardized data sheet and reviewed by two of the authors (M.I.S., G.G.). The following information was collected when available: age, sex, date and cause of death, clinical symptoms, smoking history, clinical examination, spirometry and diffusion capacity for carbon monoxide results, laboratory results, chest radiographs and chest computed tomography results, information on bronchoscopy results, indication and relative contraindications for the surgical biopsy, clinical diagnosis before and after the biopsy, treatment before and after the biopsy, and information regarding the clinical condition of the patient for the first year after the biopsy. Respiratory failure was defined as arterial partial pressure of oxygen less than 60 mm Hg needing either supplementary oxygen by nasal cannula or mask (n 6) or needing mechanical ventilation before the surgery (n 2). Patients undergoing chemotherapy or radiation for active malignant disease, patients using immunomodulating drugs or steroids as a result of organ transplantation or autoimmune diseases, patients with acquired immunodeficiency syndrome, and patients with chronic renal failure were defined as immunocompromised. The diagnosis being treated before the operation or the primary differential diagnosis mentioned was registered as the preoperative diagnosis. Pathologic Diagnosis All pathologic specimens were evaluated at the Department of Pathology at Landspitali University Hospital in Reykjavik using the Systematized Nomenclature of Medicine coding system. All lung specimens were read by one of the attending pathologists and frequently reviewed by one or more additional pathologists before codes were assigned. For the present study, all specimens were reviewed by one pathologist (H.J.I.), an experienced thoracic histopathologist. Information on the size and quality of the pathologic specimen as well as the pathologic diagnosis was obtained from pathologic reports and registered in a standardized sheet and reviewed by two of the authors (M.I.S., H.J.I.). Handling of the lung tissue has not changed during the years with the exception of the use of the tissue bank for preserving frozen tissue samples for special research purposes in rare cases. Hematoxylin and eosin staining was sufficient for making the diagnosis in most cases. In general, special stains did make much of a difference in arriving at a diagnosis. Surgical Technique and Postoperative Care Six thoracic surgeons performed the surgeries. Two techniques were used, open thoracotomies and minimally invasive technique using VATS, the latter technique being increasingly used after With a few exceptions, patients were extubated in the operating room. One chest tube (with suction of 20 cm H 2 O) was placed in the chest after the operation for the majority of patients (n 63). The tube was removed the next day if the lungs were fully expanded, no air leakage was present, and pleural drainage was less than 100 ml/24 h. Hospital morbidity was assessed by means of intraoperative and postoperative complications, reoperations, and length of stay. Extended air leakage was defined as continuous air leakage more than 96 hours postoperatively. Extended mechanical ventilation was defined as mechanical ventilation for more than 72 hours. Operative mortality was defined as the number of patients who died within 30 days of surgery. Information regarding operation type, skin to skin operation time, sample location, duration of hospital stay, duration of thoracic drainage, and operation mortality and morbidity were obtained from patient charts and surgical reports, registered in a standardized data sheet and reviewed by two of the authors (M.I.S., T.G.). Statistical Analysis Statistical analysis on categorical variables was performed using the 2 test or Fisher s exact test on 2 2 tables. Overall survival rate for the study group was estimated using the Kaplan-Meier method [14]. A probability value of less than 0.05 was considered statistically significant. Microsoft Excel (Microsoft Corp, Redmond, WA) was used for descriptive statistics; all other analysis was done using the R statistical package, version (R Foundation for Statistical Computing, Vienna, Austria).
3 Ann Thorac Surg SIGURDSSON ET AL 2009;88: SURGICAL LUNG BIOPSIES 229 Table 1. Lung Function Tests and Radiologic Evaluation a Variable Number Percentage A-a gradient Normal 11 (15) Increased 36 (49) Information not available 26 (36) Chest radiograph Normal 2 (3) Bilateral basilar interstitial change 27 (37) Patchy bilateral airspace opacities 28 (38) Unilateral diffuse airspace opacities 4 (5) Focal opacity 10 (14) Other 12 (16) Chest CT Ground glass 19 (26) Honeycombing 13 (18) Multiple nodules 23 (32) Peripheral consolidations 11 (15) Fibrosis 6 (8) Pulmonary embolism 1 (1) Pulmonary cysts 1 (1) Pleural effusion 1 (1) Not done 14 (19) a Results from lung function tests and radiologic evaluation before a surgical lung biopsy for 73 patients. A-a gradient alveolar to arterial gradient for oxygen; CT computed tomography. Results During the 22-year study period a total of 73 patients underwent an SLB for suspected ILD in Iceland, on average 3.3 patients per year with a range of 0 to 10 per year. The average age at diagnosis was 57.3 years (range, 20 to 88 years) and the number of men (58%) and women (42%) did not differ statistically (p 0.20). A vast majority of the population had a history of smoking (75%), with 53% of the patients being heavy smokers ( 20 pack-years). Table 2. Postoperative Complications and Operative Mortality a Variable Number b Percentage Postoperative complications 12 (16) Prolonged air leakage 9 (12) Need for mechanical ventilation 3 (4) Pneumonia 3 (4) Acute exacerbation of respiratory 2 (3) failure Other 1 (1) Operative mortality 30 days 2 (3) 90 days 3 (4) Hospital mortality 3 (4) a Postoperative complications and operative mortality for 73 patients undergoing surgical lung biopsy for suspected interstitial lung disease in Iceland b Some patients had more than one complication. Table 3. Pathologic Diagnosis a Variable Number Percentage Interstitial diagnosis Usual interstitial pneumonia 23 (32) Organizing pneumonia 17 (23) Nonspecific interstitial pneumonia 6 (8) Desquamative interstitial pneumonia 4 (5) Sarcoidosis 3 (4) Lymphocytic interstitial pneumonia 1 (1) Respiratory bronchiolitis-associated 1 (1) interstitial lung disease Alveolar lipoproteinosis 1 (1) Wegener s granulomatosis 1 (1) Nonspecific fibrosis 12 (16) Noninterstitial diagnosis Pneumonia 2 (3) Benign tumor 1 (1) Rheumatoid nodule 1 (1) Emphysema 1 (1) Vascular intimal fibrosis 1 (1) Nonspecific inflammation 2 (3) a Histopathologic properties of 73 patients undergoing surgical lung biopsy for suspected interstitial lung disease in Iceland The dominant presenting symptoms were dyspnea in 50 patients (68%) and cough in 43 patients (59%). The duration of symptoms was less than 3 months in 37% of patients, but 36% of patients had symptoms for more than 12 months before surgery. Blood gases were evaluated in 47 patients (64%), indicating an increased alveolar to arterial gradient for oxygen ( 10 mm Hg) for the vast majority (n 36) of patients. Preoperatively, a chest radiograph was obtained for all patients and a computed tomography scan in 59 patients (81%). The imaging studies usually revealed either multiple opacities in both lungs or interstitial changes (Table 1). Before the SLB, a transbronchial lung biopsy by means of bronchoscopy had already been obtained for 51 patients (70%) with no specific change in the rate of transbronchial biopsy frequency during the study period. Also, 2 patients had computed tomography directed biopsy. These biopsies all revealed either normal lung tissue or nonspecific inflammation. Open minithoracotomy was the most common surgical procedure (n 45; 62%), including 3 cases of VATS that were converted to thoracotomy. A total of 28 patients underwent VATS, with the majority of these operations being performed during the end of the study period (85% of operations after 2005). Operation mortality and morbidity did not differ statistically between the two procedures. Mean operation time was 46 minutes (range, 15 to 110 minutes), median chest tube drainage time was 2 days (range, 1 to 83 days), and median hospital stay was 4 days (range, 0 to 89 days). The only registered intraoperative complication was a patient with a pulmonary bleeding who required a transfusion. Postoperative complications were registered in 12
4 230 SIGURDSSON ET AL Ann Thorac Surg SURGICAL LUNG BIOPSIES 2009;88: Table 4. Comparison Between Preoperative and Postoperative Diagnosis a Postoperative Diagnosis Preoperative Diagnosis AL DIP Nonspecific Fibrosis LIP NSIP OP RBILD Sarcoidosis UIP WG Noninterstitial Disease Interstitial disease LIP 1 NSIP 1 OP 2 1 Sarcoidosis Undetermined UIP WG 1 Noninterstitial disease No diagnosis Farmers lung 1 Infection Neoplasm Pulmonary eosinophilia 1 a A contingency table showing postoperative diagnosis compared with the preoperative diagnosis for 73 patients undergoing surgical lung biopsy for suspected interstitial lung disease in Iceland AL alveolar lipoproteinosis; DIP desquamative interstitial pneumonia; LIP lymphocytic interstitial pneumonia; NSIP nonspecific interstitial pneumonia; OP organizing pneumonia; RBILD respiratory bronchiolitis-associated interstitial lung disease; UIP usual interstitial pneumonia; WG Wegener s granulomatosis. patients (16%) and are listed in Table 2. Three of these complications were major, including a bronchopleural fistula, stroke, and empyema that needed a reoperation. The most common complication, however, was prolonged air leakage in 9 patients. Three patients died in the hospital after the procedure (hospital mortality, 4.1%), all of severe respiratory failure, including 2 who died within 30 days of the procedure (operative mortality, 2.7%; Table 2). Complications were significantly more common in patients with preoperative respiratory failure (n 8) than those without (63% versus 11%; p 0.002). Hospital mortality was also higher in this subgroup of patients (25% versus 2%; p 0.03). In 51 patients (70%) a single biopsy with a maximum diameter of greater than 2 cm was obtained, and biopsies from two different lobes were performed in 17 patients (20%). Biopsies were more often from the right lung than the left (66% versus 34%; p 0.01). After the procedure, 65 patients (83%) received a definitive histopathologic diagnosis. A diagnosis of a single interstitial disease was made in 65 patients (89%), and a single diagnosis of noninterstitial disease was diagnosed in 4 patients (5%). In 4 patients (5%), both an interstitial and a noninterstitial diagnosis was obtained. Interestingly, pneumonia was diagnosed in 2 patients. In both patients, sputum cultures and cultures from bronchial washings had been performed with inadequate results. After the SLB, Pneumocystis jiroveci pneumonia and Legionella pneumonia was diagnosed by use of special stains for these patients. Both of these organisms were not suspected previously and were therefore unlikely to be detected as they both require special cultures. Detailed information on the histopathologic diagnosis of the biopsies is shown in Table 3, the most common diagnosis being usual interstitial pneumonia (32%). In a total of 14 patients (19%) there was a nonspecific histopathologic diagnosis (nonspecific interstitial fibrosis or nonspecific inflammation). In patients in whom a solitary biopsy from the lingula was performed (n 22), a nonspecific histopathologic diagnosis was not more common compared with patients with biopsies from other parts of the lungs (23% versus 18%; p 0.52). Biopsies taken from two different lobes did not increase the diagnostic efficacy of the procedure compared with a single biopsy (72% versus 73%; p 1.0). Table 4 compares preoperative and postoperative diagnosis. The diagnosis was changed for 53 (73%) patients after the SLB. When an interstitial disease of any kind was the suggested diagnosis before the operation, an interstitial disease was diagnosed in 94% of the patients. However, when a noninterstitial disease was suggested as a diagnosis before the operation, a noninterstitial disease was diagnosed in only 4% of the patients. After the biopsy, a change in treatment strategy (initiation of a new treatment, cessation of previous treatment, or a change in treatment strategy) was documented for 42 patients (53%). At 1 year of follow-up, clinical improvement was registered in 35 patients, no change in 22 patients, and 13 patients were feeling worse. Overall 2- and 5-year survival was 86% and 67%, respectively. Comment In this nationwide retrospective study we found that SLB is diagnostic for specific disease in 81% of our patients and that treatment strategy was changed for every other patient. We have addressed several unreported but important issues related to SLB in suspected ILD, such the
5 Ann Thorac Surg SIGURDSSON ET AL 2009;88: SURGICAL LUNG BIOPSIES 231 diagnostic yield of the biopsy, how often it changes the diagnosis, and how often treatment is changed. Our 73% ratio of changed diagnosis is higher than the 49% reported by Lettieri and associates [10] in their series of 83 patients with suspected Idiopathic pulmonary fibrosis. This could be attributable to several factors, such as different inclusion criteria for surgical referral. The high diagnostic yield of the surgical biopsies is of special interest, keeping in mind that two thirds of these patients already underwent a range of less invasive diagnostic studies that did not lead to a definite diagnosis. The preferred workup of suspected ILD in Iceland includes both a high-resolution computed tomography and a transbronchial biopsy unless contraindicated. In a recent study on the Icelandic population, it was found that 78% of patients with cryptogenic organizing pneumonia were diagnosed by means of a transbronchial biopsy [13]. Therefore, it is likely that a transbronchial biopsy will remain the primary diagnostic procedure for ILD. Our study, however, indicates that when transbronchial biopsies fail to reach a definite diagnosis, an SLB can be of further diagnostic benefit. The SLB is a safe procedure with a 30- and 90-day operative mortality of 2.7% and 4.1%, respectively. Our mortality rates are similar to other studies, most of them ranging from 4% to 5% and 6%, respectively [9 11]. Complications were usually minor and most often prolonged air leakage (12% of patients). This complication requires chest tube drainage and prolongs hospital stay and increases costs. Major complications were only detected in 3 patients (4%), and one of them, a stroke, was not directly related to the procedure. Patients with preoperative respiratory failure had increased mortality and morbidity, and the 3 patients who died after the procedures all died because of respiratory failure. Our findings are similar to many other studies [9, 10]. Based on our results, we cannot determine a critical point of respiratory failure at which an SLB is not safe and the patient should be treated empirically. This would, however, be an interesting and important study subject for future research. We did not find any differences in outcome after thoracotomy or VATS. This study, with its retrospective nonrandomized design, was not designed to compare these two techniques. Other studies have shown VATS to have lower mortality [11] and shorter hospital stay. From 2005 this technique has been our method of choice in Iceland. It is usually recommended to refer patients for biopsy at earlier stages, both for early treatment optimization and also because end-stage pathologic appearance of most ILDs is indistinguishable. On the other hand, suggestions about the absolute number, size, and location of the surgical biopsies vary substantially. Some surgeons favor the readily accessible lingula of the upper left lobe for the biopsy [15], whereas others find the diagnostic success from lingula biopsies unacceptable [16]. We did not find a trend for a higher rate of diagnostic failure when a solitary lingula biopsy was performed. Some earlier studies have recommended to biopsy at least two different lobes [17]. In our study multiple biopsies did not increase the diagnostic rate, and the diagnostic yield was 78% despite a single lobe biopsy for 80% of the patients. This indicates that a solitary biopsy is possibly sufficient. Our results are in line with a prior study in which multiple biopsies in 28 patients did not increase the diagnostic yield [18]. We found that the most common pathologic diagnoses obtained were usual interstitial pneumonia (32%) and organizing pneumonia (23%). Epidemiologic studies of ILD usually report that usual interstitial pneumonia is approximately 31% to 38% of ILD [19, 20], but the ratio of organizing pneumonia is around 5% [20]. Our higher ratio of organizing pneumonia could be related to a selection bias as patients with atypical presentation of ILD are more likely to be referred to an SLB. A strength of this study is its nationwide design, minimizing the risk for selection bias. Patients were identified through two different registries separately and operated on in a single cardiothoracic center by 6 surgeons. This reduces variability owing to different centers and surgeons and the likelihood that patients are missing. Furthermore, all 73 patients were treated before and after surgery by respiratory physicians, increasing the likelihood of optimal treatment. Main weaknesses are the limited number of patients and the retrospective design. Although histopathologic processing and reading remained the same, significant improvements in computed tomography imaging and surgical techniques occurred during the relatively long study period. Also, indications for referring patients for surgical biopsy were not standardized during the whole study period. In summary, we conclude that an SLB is a powerful tool for obtaining an exact diagnosis of suspected ILD, and it results in changes in the clinical diagnosis and a new treatment strategy for the majority of patients. The operative morbidity and mortality is low but significant, so patients should be carefully selected for the procedure. This is important for patients with severe respiratory failure. References 1. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June Am J Respir Crit Care Med 2002;165: American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161: Halkos M, Gal A, Kerendi F, et al. Role of thoracic surgeons in the diagnosis of idiopathic interstitial lung disease. Ann Thorac Surg 2005; Hunninghake GW, Zimmerman MB, Schwartz DA, et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001;164:
6 232 SIGURDSSON ET AL Ann Thorac Surg SURGICAL LUNG BIOPSIES 2009;88: Raghu G, Mageto YN, Lockhart D, et al. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: a prospective study. Chest 1999;116: Flaherty KR, King TE Jr, Raghu G, et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med 2004;170: Flaherty KR, Andrei AC, King TE Jr, et al. Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? Am J Respir Crit Care Med 2007;175: Gal AA. Use and abuse of lung biopsy. Adv Anat Pathol 2005;12: Park J, Kim D, Kim D, et al. Mortality and risk factors for surgical lung biopsy in patients with idiopathic interstitial pneumonia. Eur J Cardiothorac Surg 2007; Lettieri CJ, Veerappan GR, Helman DL, et al. Outcomes and safety of surgical lung biopsy for interstitial lung disease. Chest 2005;127: Tiitto L, Heiskanen U, Bloigu R, Pääkkö P, Kinnula V, Kaarteenaho-Wiik R. Thoracoscopic lung biopsy is a safe procedure in diagnosing usual interstitial pneumonia. Chest 2005;128: Ravini M, Ferraro G, Barbieri B, Colombo P, Rizzato G. Changing strategies of lung biopsies in diffuse lung diseases: the impact of video-assisted thoracoscopy. Eur Respir J 1998;11: Sveinsson OA, Isaksson HJ, Sigvaldason A, et al. Clinical features in secondary and cryptogenic organising pneumonia. Int J Tuberc Lung Dis 2007;11: Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53: Ayed AK. Video-assisted thoracoscopic lung biopsy in the diagnosis of diffuse interstitial lung disease. A prospective study. J Cardiovasc Surg (Torino) 2003;44: Monaghan H, Wells AU, Colby TV, et al. Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias. Chest 2004;125: Klassen KP, Andrews NC. Biopsy of diffuse pulmonary lesions: A seventeen-year experience. Ann Thorac Surg 1967;4: Flint A, Martinez FJ, Young ML, et al. Influence of sample number and biopsy site on the histologic diagnosis of diffuse lung disease. Ann Thorac Surg 1995;60: Demedts M, Wells AU, Anto JM, et al. Interstitial lung diseases: an epidemiological overview. Eur Respir J Suppl 2001;32:2s Lopez-Campos JL, Rodriguez-Becerra E. Incidence of interstitial lung diseases in the south of Spain : the RENIA study. Eur J Epidemiol 2004;19: INVITED COMMENTARY This article [1] is particularly useful because it addresses a specific subset of patients who are potential candidates for surgical lung biopsy. It includes only patients with interstitial lung disease (ILD). What it does not include is patients with acute respiratory distress syndrome (ARDS) or patients with pulmonary masses who are candidates for a wedge resection for either diagnosis or treatment. Focusing solely on this particular subset of patients allows conclusions that are not confounded by the inclusion of these other types of patients. Therefore, the observations and conclusions for patients with ILD are credible and useful. Their findings are that the clinical diagnosis was changed in 73% of their patients and the revised diagnosis resulted in treatment changes in 53% of patients. The cost for this was a modest morbidity and an in-hospital mortality rate of 4.1%. Consistent with previous reports, these results document a significant positive impact on clinical care as a result of these biopsy findings. However, another perspective is that the procedure did not affect the clinical care of half the patients, and while the mortality and morbidity rates seem low, they are not absent. In this context, I agree with the author s suggested algorithm for the approach to patients with ILD. The initial diagnostic evaluation, in addition to the patient s history, should begin with a high resolution computed tomographic scan of the chest and a transbronchial biopsy. According to the authors experience, this will be diagnostic in 78% of patients. This leaves a small number of patients to be considered for surgical biopsy, which should be performed when patients are not responding appropriately to the ongoing management based on their clinical diagnosis. For the biopsy procedure, either a limited thoracotomy or a video-assisted thoracic surgical (VATS) procedure is a reasonable option. Although not shown in this study, video-assisted thoracic surgery is probably superior (both in terms of pain control and access to multiple lung areas) for biopsy. However, there is sufficient morbidity and mortality that even a VATS procedure should not be performed simply out of curiosity, but only if patient management might be affected. Alex G. Little, MD Department of Surgery Wright State University Boonshoft School of Medicine One Wyoming St 7801 WCHE Dayton, OH alex.little@wright.edu Reference 1. Sigurdsson MI, Isaksson HJ, Gudmundsson G, Gudbjartsson T. Diagnostic surgical lung biopsies for suspected interstitial lung diseases: a retrospective study. Ann Thorac Surg 2009;88: by The Society of Thoracic Surgeons /09/$36.00 Published by Elsevier Inc doi: /j.athoracsur
CTD-related Lung Disease
13 th Cambridge Chest Meeting King s College, Cambridge April 2015 Imaging of CTD-related Lung Disease Dr Sujal R Desai King s College Hospital, London Disclosure Statement No Disclosures / Conflicts of
More information5/9/2015. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. No, I am not a pulmonologist! Radiology
Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective No, I am not a pulmonologist! Radiology Pathology Clinical 1 Everyone needs a CT Confidence in diagnosis Definitive HRCT +
More informationLiebow and Carrington's original classification of IIP
Liebow and Carrington's original classification of IIP-- 1969 Eric J. Stern MD University of Washington UIP Usual interstitial pneumonia DIP Desquamative interstitial pneumonia BIP Bronchiolitis obliterans
More information11/10/2014. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. Radiology
Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective Radiology Pathology Clinical 1 Role of HRCT Diagnosis Fibrosis vs. inflammation Next step in management Response to treatment
More informationComplications of Video-Assisted Thoracoscopic Lung Biopsy in Patients with Interstitial Lung Disease
Complications of Video-Assisted Thoracoscopic Lung Biopsy in Patients with Interstitial Lung Disease Mary Elizabeth Kreider, MD, MS, John Hansen-Flaschen, MD, Nadia N. Ahmad, MD, Milton D. Rossman, MD,
More informationINTERSTITIAL LUNG DISEASE. Radhika Reddy MD Pulmonary/Critical Care Long Beach VA Medical Center January 5, 2018
INTERSTITIAL LUNG DISEASE Radhika Reddy MD Pulmonary/Critical Care Long Beach VA Medical Center January 5, 2018 Interstitial Lung Disease Interstitial Lung Disease Prevalence by Diagnosis: Idiopathic Interstitial
More informationProgress in Idiopathic Pulmonary Fibrosis
Progress in Idiopathic Pulmonary Fibrosis David A. Lynch, MB Disclosures Progress in Idiopathic Pulmonary Fibrosis David A Lynch, MB Consultant: t Research support: Perceptive Imaging Boehringer Ingelheim
More informationFinancial disclosure COMMON DIAGNOSES IN HRCT. High Res Chest HRCT. HRCT Pre test. I have no financial relationships to disclose. Anatomy Nomenclature
Financial disclosure I have no financial relationships to disclose. Douglas Johnson D.O. Cardiothoracic Imaging Gaston Radiology COMMON DIAGNOSES IN HRCT High Res Chest Anatomy Nomenclature HRCT Sampling
More informationCase Presentations in ILD. Harold R. Collard, MD Department of Medicine University of California San Francisco
Case Presentations in ILD Harold R. Collard, MD Department of Medicine University of California San Francisco Outline Overview of diagnosis in ILD Definition/Classification High-resolution CT scan Multidisciplinary
More informationThoracic Surgery; An Overview
Thoracic Surgery What we see Thoracic Surgery; An Overview James P. Locher, Jr, MD Methodist Cardiovascular and Thoracic Surgery Lung cancer Mets Fungus and TB Lung abcess and empyema Pleural based disease
More informationDiffuse Interstitial Lung Diseases: Is There Really Anything New?
: Is There Really Anything New? Sujal R. Desai, MBBS, MD ESTI SPEAKER SUNDAY Society of Thoracic Radiology San Antonio, Texas March 2014 Diffuse Interstitial Lung Disease The State of Play DILDs Is There
More informationBronchoalveolar Lavage and Histopathologic Diagnosis Based on Biopsy
Idiopathic Pulmonary Fibrosis Bronchoalveolar Lavage and Histopathologic Diagnosis Based on Biopsy JMAJ 46(11): 469 474, 2003 Yukihiko SUGIYAMA Professor, Division of Pulmonary Medicine, Department of
More informationOutline Definition of Terms: Lexicon. Traction Bronchiectasis
HRCT OF IDIOPATHIC INTERSTITIAL PNEUMONIAS Disclosures Genentech, Inc. Speakers Bureau Tadashi Allen, MD University of Minnesota Assistant Professor Diagnostic Radiology 10/29/2016 Outline Definition of
More informationDifferential diagnosis
Differential diagnosis Idiopathic pulmonary fibrosis (IPF) is part of a large family of idiopathic interstitial pneumonias (IIP), one of four subgroups of interstitial lung disease (ILD). Differential
More informationInternational consensus statement on idiopathic pulmonary fibrosis
Eur Respir J 2001; 17: 163 167 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2001 European Respiratory Journal ISSN 0903-1936 PERSPECTIVE International consensus statement on idiopathic
More informationMethods ROLE OF OPEN LUNG BIOPSY IN PATIENTS WITH DIFFUSE LUNG INFILTRATES AND ACUTE RESPIRATORY FAILURE
ROLE OF OPEN LUNG BIOPSY IN PATIENTS WITH DIFFUSE LUNG INFILTRATES AND ACUTE RESPIRATORY FAILURE Li-Hui Soh, Chih-Feng Chian, Wen-Lin Su, Horng-Chin Yan, Wann-Cherng Perng, and Chin-Pyng Wu Background
More informationPulmonary manifestations of CTDs Diagnosis, differential diagnosis and treatment
Prague, June 2014 Pulmonary manifestations of CTDs Diagnosis, differential diagnosis and treatment Katerina M. Antoniou, MD, PhD As. Professor in Thoracic Medicine ERS ILD Group Secretary Medical School,
More informationNon-neoplastic Lung Disease II
Pathobasic Non-neoplastic Lung Disease II Spasenija Savic Prince Pathology Program Systematic approach to surgical lung biopsies with ILD Examples (chronic ILD): Idiopathic interstitial pneumonias: UIP,
More informationNonspecific interstitial pneumonia and usual interstitial pneumonia: comparison of the clinicopathologic features and prognosis
Original Article Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparison of the clinicopathologic features and prognosis Xia Li 1, Chang Chen 2, Jinfu Xu 1, Jinming Liu 1, Xianghua
More informationImaging: how to recognise idiopathic pulmonary fibrosis
REVIEW IDIOPATHIC PULMONARY FIBROSIS Imaging: how to recognise idiopathic pulmonary fibrosis Anand Devaraj Affiliations: Dept of Radiology, St George s Hospital, London, UK. Correspondence: Anand Devaraj,
More informationCryptogenic Organizing Pneumonia Diagnosis Approach Based on a Clinical-Radiologic-Pathologic Consensus
Cryptogenic Organizing Pneumonia Diagnosis Approach Based on a Clinical-Radiologic-Pathologic Consensus Poster No.: C-1622 Congress: ECR 2012 Type: Scientific Exhibit Authors: C. Cordero Lares, E. Zorita
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Idiopathic Pulmonary Fibrosis Page 1 of 10 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Idiopathic Pulmonary Fibrosis (Esbriet /pirfenidone, Ofev /nintedanib)
More information4/17/2010 C ini n ca c l a Ev E a v l a ua u t a ion o n of o ILD U dat a e t e i n I LDs
Update in ILDs Diagnosis 101: Clinical Evaluation April 17, 2010 Jay H. Ryu, MD Mayo Clinic, Rochester MN Clinical Evaluation of ILD Outline General aspects of ILDs Classification of ILDs Clinical evaluation
More informationEfficacy and safety of surgical lung biopsy for interstitial disease. Experience of 161 consecutive patients from a single institution in Italy
Original article: Clinical research SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES 2015; 32; 251-258 Mattioli 1885 Efficacy and safety of surgical lung biopsy for interstitial disease. Experience of
More informationThe Egyptian Journal of Hospital Medicine (July 2017) Vol.68 (2), Page
The Egyptian Journal of Hospital Medicine (July 2017) Vol.68 (2), Page 1135-1140 Role of High Resolution Computed Tomography in Diagnosis of Interstitial Lung Diseases in Patients with Collagen Diseases
More informationDiffuse interstitial lung diseases (DILDs) are a heterogeneous group of non-neoplastic, noninfectious
Focused Issue of This Month Diagnostic Approaches to Diffuse Interstitial Lung Diseases Dong Soon Kim, MD Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine E -
More informationInfluence of Smoking in Interstitial Pneumonia Presenting with a Non-Specific Interstitial Pneumonia Pattern
ORIGINAL ARTICLE Influence of Smoking in Interstitial Pneumonia Presenting with a Non-Specific Interstitial Pneumonia Pattern Tetsuro Sawata, Masashi Bando, Masayuki Nakayama, Naoko Mato, Hideaki Yamasawa
More informationUnpaid scientific collaborator & advisor with Veracyte, Inc.
Diagnosis and Classification of Idiopathic Interstitial Pneumonias: Role of Histopathology in the Golden Age of Consensus Jeffrey L. Myers, M.D. A. James French Professor of Diagnostic Pathology Vice Chair
More informationConnective Tissue Disorder- Associated Interstitial Lung Disease (CTD-ILD) and Updates
Connective Tissue Disorder- Associated Interstitial Lung Disease (CTD-ILD) and Updates Maria Elena Vega, M.D Assistant Professor of Medicine Lewis Katz School of Medicine at Temple University Nothing to
More informationDIAGNOSTIC NOTE TEMPLATE
DIAGNOSTIC NOTE TEMPLATE SOAP NOTE TEMPLATE WHEN CONSIDERING A DIAGNOSIS OF IDIOPATHIC PULMONARY FIBROSIS (IPF) CHIEF COMPLAINT HISTORY OF PRESENT ILLNESS Consider IPF as possible diagnosis if any of the
More informationOBJECTIVES. Solitary Solid Spiculated Nodule. What would you do next? Case Based Discussion: State of the Art Management of Lung Nodules.
Organ Imaging : September 25 2015 OBJECTIVES Case Based Discussion: State of the Art Management of Lung Nodules Dr. Elsie T. Nguyen Dr. Kazuhiro Yasufuku 1. To review guidelines for follow up and management
More informationERS 2016 Congress Highlights Interstitial Lung Disease (ILD)
ERS 216 Congress Highlights Interstitial Lung Disease (ILD) London, UK September 3 rd 7 th 216 The 26 th European Respiratory Society International Congress, (ERS) the largest respiratory meeting in the
More informationEpidemiology and classification of smoking related interstitial lung diseases
Epidemiology and classification of smoking related interstitial lung diseases Šterclová M. Department of Respiratory Diseases, Thomayer Hospital, Prague, Czech Republic Supported by an IGA Grant No G 1207
More informationTBLB is not recommended as the initial biopsy option in cases of suspected IPF and is unreliable in the diagnosis of rare lung disease (other than
TBLB is not recommended as the initial biopsy option in cases of suspected IPF and is unreliable in the diagnosis of rare lung disease (other than PAP) BAL is not required as a diagnostic tool in patients
More informationThoracoscopy for Lung Cancer
Thoracoscopy for Lung Cancer Introduction The occurrence of lung cancer has increased dramatically over the last 50 years. Your doctor may have recommended an operation to remove your lung cancer. The
More informationMay-Lin Wilgus. A. Study Purpose and Rationale
Utility of a Computer-Aided Diagnosis Program in the Evaluation of Solitary Pulmonary Nodules Detected on Computed Tomography Scans: A Prospective Observational Study May-Lin Wilgus A. Study Purpose and
More informationT he diagnostic evaluation of a patient with
546 REVIEW SERIES Challenges in pulmonary fibrosis? 1: Use of high resolution CT scanning of the lung for the evaluation of patients with idiopathic interstitial pneumonias Michael B Gotway, Michelle M
More informationIPF: Epidemiologia e stato dell arte
IPF: Epidemiologia e stato dell arte Clinical Classification Diffuse parenchimal lung diseases Exposure-related: - occupational - environmental - medication Desquamative interstitial pneumonia Idiopathic
More informationThoracic lung involvement in rheumatoid arthritis: Findings on HRCT
Thoracic lung involvement in rheumatoid arthritis: Findings on HRCT Poster No.: C-2488 Congress: ECR 2015 Type: Educational Exhibit Authors: R. E. Correa Soto, M. J. Martín Sánchez, J. M. Fernandez 1 1
More informationSystemic lupus erythematosus (SLE): Pleuropulmonary Manifestations
08/30/10 09/26/10 Systemic lupus erythematosus (SLE): Pleuropulmonary Manifestations Camila Downey S. Universidad de Chile, School of Medicine, Year VII Harvard University, School of Medicine Sept 17,
More informationIdiopathic Pulmonary Fibrosis: The Importance of Qualitative and Quantitative Phenotyping
Idiopathic Pulmonary Fibrosis: The Importance of Qualitative and Quantitative Phenotyping K. R. Flaherty Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor,
More informationA Review of Interstitial Lung Diseases
Outline A Review of Interstitial Lung Diseases Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco Overview of diagnosis in ILD Why it is important Definition/Classification
More informationA Review of Interstitial Lung Diseases. Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco
A Review of Interstitial Lung Diseases Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco Outline Overview of diagnosis in ILD Why it is important Definition/Classification
More informationINVITED REVIEW SERIES: PULMONARY FIBROSIS SERIES EDITORS: MARTIN KOLB AND GERARD COX
INVITED REVIEW SERIES: PULMONARY FIBROSIS SERIES EDITORS: MARTIN KOLB AND GERARD COX Diagnosing fibrotic lung disease: When is high-resolution computed tomography sufficient to make a diagnosis of idiopathic
More informationLung Cancer Resection
Lung Cancer Resection Introduction The occurrence of lung cancer has increased dramatically over the last 50 years. Your health care provider may have recommended an operation to remove your lung cancer.
More informationCase Study #2. Case Study #1 cont 9/28/2011. CAPA 2011 Christy Wilson PA C. LH is 78 yowf with PMHx of metz breast CA presents
Case Study #1 CAPA 2011 Christy Wilson PA C 46 yo female presents with community acquired PNA (CAP). Her condition worsened and she was transferred to the ICU and placed on mechanical ventilation. Describe
More informationFocal Organizing Pneumonia on Surgical Lung Biopsy* Causes, Clinicoradiologic Features, and Outcomes
CHEST Focal Organizing Pneumonia on Surgical Lung Biopsy* Causes, Clinicoradiologic Features, and Outcomes Fabien Maldonado, MD; Craig E. Daniels, MD; Elizabeth A. Hoffman, MD; Eunhee S. Yi, MD; and Jay
More informationI diopathic pulmonary fibrosis (IPF) is the most common
1091 INTERSTITIAL LUNG DISEASE Relationship between histopathological features and the course of idiopathic pulmonary fibrosis/usual interstitial pneumonia L Tiitto, R Bloigu, U Heiskanen, P Pääkkö, V
More informationNONE OVERVIEW FINANCIAL DISCLOSURES UPDATE ON IDIOPATHIC PULMONARY FIBROSIS/IPF (UIP) FOR PATHOLOGISTS. IPF = Idiopathic UIP Radiologic UIP Path UIP
UPDATE ON IDIOPATHIC PULMONARY FIBROSIS/IPF () FOR PATHOLOGISTS Thomas V. Colby, M.D. Professor of Pathology (Emeritus) Mayo Clinic Arizona FINANCIAL DISCLOSURES NONE OVERVIEW IPF Radiologic Dx Pathologic
More informationCombined Unclassifiable Interstitial Pneumonia and Emphysema: A Report of Two Cases
CASE REPORT Combined Unclassifiable Interstitial Pneumonia and Emphysema: A Report of Two Cases Nobuhiko Nagata 1, Kentaro Watanabe 2, Michihiro Yoshimi 3, Hiroshi Okabayashi 4, Katsuo Sueishi 5, Kentaro
More informationCase 4 History. 58 yo man presented with prox IP joint swelling 2 months later pain and swelling in multiple joints Chest radiograph: bi-basilar
Case 4 History 58 yo man presented with prox IP joint swelling 2 months later pain and swelling in multiple joints Chest radiograph: bi-basilar basilar infiltrates suggestive of pulmonary fibrosis Open
More informationAn earlier and more confident diagnosis of idiopathic pulmonary fibrosis
Eur Respir Rev 2012; 21: 124, 141 146 DOI: 10.1183/09059180.00000812 CopyrightßERS 2012 REVIEW: IPF An earlier and more confident diagnosis of idiopathic pulmonary fibrosis Roland M. du Bois ABSTRACT:
More informationThe Spectrum of Management of Pulmonary Ground Glass Nodules
The Spectrum of Management of Pulmonary Ground Glass Nodules Stanley S Siegelman CT Society 10/26/2011 No financial disclosures. Noguchi M et al. Cancer 75: 2844-2852, 1995. 236 surgically resected peripheral
More informationINHALED TREPROSTINIL IN PULMONARY HYPERTENSION DUE TO INTERSTITIAL LUNG DISEASE (PH-ILD)
THE INCREASE STUDY INHALED TREPROSTINIL IN PULMONARY HYPERTENSION DUE TO INTERSTITIAL LUNG DISEASE (PH-ILD) Peter Smith, PharmD Senior Director Product Development, United Therapeutics Corporation 2 SAFE
More informationAcute Exacerbation of Usual Interstitial Pneumonia After Resection of Lung Cancer
Acute Exacerbation of Usual Interstitial Pneumonia After Resection of Lung Cancer Hiroaki Sugiura, MD, Atsuya Takeda, MD, PhD, Toshiko Hoshi, MD, PhD, Yoshinori Kawabata, MD, Koichi Sayama, MD, PhD, Masahiro
More informationUsual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease
Eur Respir J 2010; 35: 1322 1328 DOI: 10.1183/09031936.00092309 CopyrightßERS 2010 Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease E.J. Kim*, B.M. Elicker #, F.
More informationDIFFERENCES IN FIBROPROLIFERATIVE HEALING IN EXOGENEOUS AND IDIOPATHIC ILDs. ARE THERE ANY?
NIHR Southampton Respiratory Biomedical Research Unit DIFFERENCES IN FIBROPROLIFERATIVE HEALING IN EXOGENEOUS AND IDIOPATHIC ILDs. ARE THERE ANY? Fibrosing Interstitial Lung Diseases CPFS/WASOG/AIPO/ERS
More informationSubpleural Honeycombing on High Resolution Computed Tomography is Risk Factor for Fatal Pneumonitis
Subpleural Honeycombing on High Resolution Computed Tomography is Risk Factor for Fatal Pneumonitis Hiroyuki Ito, MD, Haruhiko Nakayama, MD, Masahiro Tsuboi, MD, MD, Yoichi Kameda, MD, Tomoyuki Yokose,
More informationFollicular bronchiolitis in surgical lung biopsies: Clinical implications in 12 patients
Respiratory Medicine (2008) 102, 307 312 Follicular bronchiolitis in surgical lung biopsies: Clinical implications in 12 patients Michelle R. Aerni a, Robert Vassallo a,, Jeffrey L. Myers b, Rebecca M.
More informationDiagnosing Idiopathic Pulmonary Fibrosis on Evidence-Based Guidelines
Diagnosing Idiopathic Pulmonary Fibrosis on Evidence-Based Guidelines Rebecca Keith, MD Assistant Professor, Division of Pulmonary and Critical Care Medicine National Jewish Health, Denver, CO Objectives
More informationWedge Biopsy for Diffuse Lung Diseases
Chapter VI Wedge Biopsy for Diffuse Lung Diseases Wedge biopsy via thoracoscopic biopsy or open lung biopsy is occasionally performed to obtain tissue for the diagnosis of a diffuse lung disease. A wedge
More informationIn medicine, the term overlap is very common, to the extent that there is even a
Case Report Payam Mehrian (MD) 1 Ali Cheraghvandi (MD) 2 Atousa Droudnia (PhD) 3 Firouzeh Talischi (MD) 4 Saeid Fallah Tafti (MD) *5 Shahram Kahkouee (MD) 6 Hamidreza Jamaati (MD) 7 1. Pediatric Respiratory
More informationARDS - a must know. Page 1 of 14
ARDS - a must know Poster No.: C-1683 Congress: ECR 2016 Type: Authors: Keywords: DOI: Educational Exhibit M. Cristian; Turda/RO Education and training, Edema, Acute, Localisation, Education, Digital radiography,
More informationCT Screening for Lung Cancer for High Risk Patients
CT Screening for Lung Cancer for High Risk Patients The recently published National Lung Cancer Screening Trial (NLST) showed that low-dose CT screening for lung cancer reduces mortality in high-risk patients
More informationJune 2013 Pulmonary Case of the Month: Diagnosis Makes a Difference. Lewis J. Wesselius, MD 1 Henry D. Tazelaar, MD 2
June 2013 Pulmonary Case of the Month: Diagnosis Makes a Difference Lewis J. Wesselius, MD 1 Henry D. Tazelaar, MD 2 Departments of Pulmonary Medicine 1 and Laboratory Medicine and Pathology 2 Mayo Clinic
More informationSurgery has been proven to be beneficial for selected patients
Thoracoscopic Lung Volume Reduction Surgery Robert J. McKenna, Jr, MD Surgery has been proven to be beneficial for selected patients with severe emphysema. Compared with medical management, lung volume
More informationARTICLE IN PRESS. Ahuva Grubstein a, Daniele Bendayan b, Ithak Schactman c, Maya Cohen a, David Shitrit b, Mordechai R. Kramer b,
Respiratory Medicine (2005) 99, 948 954 Concomitant upper-lobe bullous emphysema, lower-lobe interstitial fibrosis and pulmonary hypertension in heavy smokers: report of eight cases and review of the literature
More informationOverview of Idiopathic Pulmonary Fibrosis: Diagnosis and Therapy
Overview of Idiopathic Pulmonary Fibrosis: Diagnosis and Therapy Jeff Swigris, DO, MS Director, ILD Program National Jewish Health Disclosures Speaker - Boehringer Ingelheim and Genentech Objectives Describe
More informationCommon things are common, but not always the answer
Kevin Conroy, Joe Mackenzie, Stephen Cowie kevin.conroy@nhs.net Respiratory Dept, Darlington Memorial Hospital, Darlington, UK. Common things are common, but not always the answer Case report Cite as:
More informationCase 1 : Question. 1.1 What is the intralobular distribution? 1. Centrilobular 2. Perilymphatic 3. Random
Interesting case Case 1 Case 1 : Question 1.1 What is the intralobular distribution? 1. Centrilobular 2. Perilymphatic 3. Random Case 1: Answer 1.1 What is the intralobular distribution? 1. Centrilobular
More informationHypersensitivity Pneumonitis Common Diagnostic and Treatment Dilemmas
Hypersensitivity Pneumonitis Common Diagnostic and Treatment Dilemmas Rishi Raj MD Director, Interstitial Lung Diseases Program Clinical Professor of Pulmonary and Critical Care Medicine Stanford University
More informationIdiopathic interstitial pneumonias (IIPs) are a group of
SYMPOSIA C. Isabela S. Silva, MD, PhD and Nestor L. Müller, MD, PhD Abstract: The idiopathic interstitial pneumonias (IIPs) are a group of diffuse parenchymal lung diseases of unknown etiology characterized
More informationSurgical indications: Non-malignant pulmonary diseases. Punnarerk Thongcharoen
Surgical indications: Non-malignant pulmonary diseases Punnarerk Thongcharoen Non-malignant Malignant as a pathological term: Cancer Non-malignant = not cancer Malignant as an adjective: Disposed to cause
More informationNavigational bronchoscopy-guided dye marking to assist resection of a small lung nodule
Case Report on Aerodigestive Endoscopy Navigational bronchoscopy-guided dye marking to assist resection of a small lung nodule Jennifer L. Sullivan 1, Michael G. Martin 2, Benny Weksler 1 1 Division of
More informationAdam J. Hansen, MD UHC Thoracic Surgery
Adam J. Hansen, MD UHC Thoracic Surgery Sometimes seen on Chest X-ray (CXR) Common incidental findings on computed tomography (CT) chest and abdomen done for other reasons Most lung cancers discovered
More informationDiagnostic challenges in IPF
Medicine, Nursing and Health Sciences Diagnostic challenges in IPF Dr Ian Glaspole Central and Eastern Clinical School, Alfred Hospital and Monash University March 2015 Disclosures Consultancy fees from
More informationTreatment of Clinical Stage I Lung Cancer: Thoracoscopic Lobectomy is the Standard
Treatment of Clinical Stage I Lung Cancer: Thoracoscopic Lobectomy is the Standard AATS General Thoracic Surgery Symposium May 5, 2010 Thomas A. D Amico MD Professor of Surgery, Duke University Medical
More informationDisclosures. Fibrotic lung diseases: Basic Principles, Common Problems, and Reporting. Relevant financial relationships: None. Off-label usage: None
Fibrotic lung diseases: Basic Principles, Common Problems, and Reporting Brandon T. Larsen, MD, PhD Senior Associate Consultant Department of Laboratory Medicine and Pathology Mayo Clinic Arizona Arizona
More informationAlper Toker, MD. VATS decortication. Istanbul University, Istanbul Medical School Department of Thoracic Surgery
VATS decortication Alper Toker, MD Istanbul University, Istanbul Medical School Department of Thoracic Surgery Pleural space infection is a common pathology causing morbidity and mortality. It is a collection
More informationPrognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis
Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis JULIE A. BJORAKER, JAY H. RYU, MARK K. EDWIN, JEFFREY L. MYERS, HENRY D. TAZELAAR, DARRELL R. SCHROEDER, and KENNETH
More informationCurrent diagnostic recommendations for ILD: The multidisciplinary meeting TSANZSRS ASM
Medicine, Nursing and Health Sciences Current diagnostic recommendations for ILD: The multidisciplinary meeting Dr Ian Glaspole Central and Eastern Clinical School, Alfred Hospital and Monash University
More informationLUNG NODULES: MODERN MANAGEMENT STRATEGIES
Department of Radiology LUNG NODULES: MODERN MANAGEMENT STRATEGIES Christian J. Herold M.D. Department of Biomedical Imaging and Image-guided Therapy Medical University of Vienna Vienna, Austria Pulmonary
More informationNew respiratory symptoms and lung imaging findings in a woman with polymyositis
Maria Bolaki 1, Konstantinos Karagiannis 1, George Bertsias 2, Ioanna Mitrouska 1, Nikolaos Tzanakis 1, Katerina M. Antoniou 1 kantoniou@uoc.gr 1 Dept of Thoracic Medicine, Heraklion University Hospital,
More informationA Comparative Study of Video-Assisted Thoracic Surgery with Thoracotomy for Middle Lobe Syndrome
World J Surg (2017) 41:780 784 DOI 10.1007/s00268-016-3777-6 ORIGINAL SCIENTIFIC REPORT A Comparative Study of Video-Assisted Thoracic Surgery with Thoracotomy for Middle Lobe Syndrome Jian Li 1,2 Chengwu
More informationDaria Manos RSNA 2016 RC 401. https://medicine.dal.ca/departments/depar tment-sites/radiology/contact/faculty/dariamanos.html
Daria Manos RSNA 2016 RC 401 https://medicine.dal.ca/departments/depar tment-sites/radiology/contact/faculty/dariamanos.html STEP1: Is this fibrotic lung disease? STEP 2: Is this a UIP pattern? If yes:
More informationThoracoscopic Lobectomy for Locally Advanced Lung Cancer. Masters of Minimally Invasive Thoracic Surgery Orlando September 19, 2014
for Locally Advanced Lung Cancer Masters of Minimally Invasive Thoracic Surgery Orlando September 19, 2014 Thomas A. D Amico MD Gary Hock Endowed Professor and Vice Chair of Surgery Chief Thoracic Surgery
More informationIPF AND OTHER FIBROSING LUNG DISEASE: WHAT DRUGS MIGHT WORK AND ON WHOM DO THEY W ORK?
IPF AND OTHER FIBROSING LUNG DISEASE: WHAT DRUGS MIGHT WORK AND ON WHOM DO THEY W ORK? KEVIN K. BROWN, MD PROFESSOR AND VICE CHAIRMAN, DEPARTMENT OF MEDICINE NATIONAL JEWISH HEALTH DENVER, CO Kevin K.
More informationDisclosures. Traditional Paradigm. Overview 4/17/2010. I have relationships with the following organizations and companies:
Disclosures Pharmacological Therapy for ILD What to Use and How to Use It Harold R Collard MD Interstitial Lung Disease Program University of California San Francisco (UCSF) I have relationships with the
More informationIPF - Inquadramento clinico
IPF - Inquadramento clinico Sergio Harari Unità Operativa di Pneumologia UTIR Servizio di Fisiopat. Resp. e Emodinamica Polmonare Ospedale S. Giuseppe, Milano Clinical Classification Diffuse parenchimal
More informationUniportal video-assisted thoracoscopic surgery segmentectomy
Case Report on Thoracic Surgery Page 1 of 5 Uniportal video-assisted thoracoscopic surgery segmentectomy John K. C. Tam 1,2 1 Division of Thoracic Surgery, National University Heart Centre, Singapore;
More informationUsual Interstitial pneumonia and Nonspecific Interstitial Pneumonia. Nitra and the Gangs.
Usual Interstitial pneumonia and Nonspecific Interstitial Pneumonia Nitra and the Gangs. บทน ำและบทท ๓, ๑๐, ๑๒, ๑๓, ๑๔, ๑๕, ๑๗ Usual Interstitial Pneumonia (UIP) Most common & basic pathologic pattern
More informationInterventional procedures guidance Published: 20 December 2017 nice.org.uk/guidance/ipg600
Endobronchial valve insertion to reduce lung volume in emphysema Interventional procedures guidance Published: 20 December 2017 nice.org.uk/guidance/ipg600 Your responsibility This guidance represents
More informationThe radiological differential diagnosis of the UIP pattern
5th International Conference on Idiopathic Pulmonary Fibrosis, Modena, 2015, June 12th The radiological differential diagnosis of the UIP pattern Simon Walsh King s College Hospital Foundation Trust London,
More informationFacing Surgery for Lung Cancer? Learn about minimally invasive da Vinci Surgery
Facing Surgery for Lung Cancer? Learn about minimally invasive da Vinci Surgery Treatments & Surgery Options: The treatment and surgical options for the most common lung cancer, non-small cell lung cancer,
More information9/15/11. Dr. Vivien Hsu Director, UMDNJ Scleroderma Program New Brunswick, NJ September Scleroderma. Hard skin
Dr. Vivien Hsu Director, UMDNJ Scleroderma Program New Brunswick, NJ September 2011 Scleroderma Hard skin 1 No diagnostic test for scleroderma Pathogenesis is unknown prominent features of disease reflect
More informationCASE REPORT. Introduction. Case series reports. J Thorac Dis 2012;4(S1): DOI: /j.issn s003
CASE REPORT Lost in time pulmonary metastases of renal cell carcinoma: complete surgical resection of metachronous metastases, 18 and 15 years after nephrectomy Kosmas Tsakiridis 1, Aikaterini N Visouli
More informationSuperior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis
ORIGINAL ARTICLES: Superior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis Shun-ichi Watanabe, MD, Kenji Suzuki, MD, and Hisao Asamura, MD
More informationBronchogenic Carcinoma
A 55-year-old construction worker has smoked 2 packs of ciggarettes daily for the past 25 years. He notes swelling in his upper extremity & face, along with dilated veins in this region. What is the most
More informationTHORACIK RICK. Lungs. Outline and objectives Richard A. Malthaner MD MSc FRCSC FACS
THORACIK RICK Outline and objectives Lungs Management of a solitary lung nodule Mediastinum Management of a mediastinal mass Pleura Management of a pleural fluid & pneumothorax Esophagus & Stomach Management
More information